Turkey: Trade mark prosecution and opposition under the new IP Code

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Turkey: Trade mark prosecution and opposition under the new IP Code

The New Turkish Industrial Property Code entered into force on January 10 2017. The IP Code replaces the Decree-laws pertaining to the protection of trade marks, patents, geographical indications and designs by unifying them into a single code.

Among other reforms, the trade mark chapter includes changes relating to prosecution and opposition procedures for trade marks. These are now in greater compliance with the relevant European Union directives.

First, the graphical representation criteria for signs to be registered as a trade mark has changed to "signs capable of being represented on the register in a manner which enables the competent authorities and the public to determine the clear and precise subject matter of the protection afforded to its proprietor". Further, "colours" and "sounds" have been explicitly stated under "signs" that can be registered as a "trade mark" for the first time. In addition, it has been explicitly stated that the signs that are not distinctive and which include geographical indications cannot be registered. Those were already accepted under the former legislation through interpretation but now they are clearly mentioned in the IP Code.

One of the major changes in trade mark prosecution is that the IP Code introduces the principle of co-existence into Turkish trade mark law. Accordingly, letters of consent from the senior trade mark/trade mark application owners will be acceptable in overcoming the citations of earlier senior identical or indistinguishably similar trade marks by the Turkish Patent and Trade Mark Office as an ex officio refusal ground.

The IP Code includes major changes relating to the opposition proceedings as well. First, the term for opposition for trade marks has been shortened to two months from three months. Further, during the opposition proceedings before the Office opponents will have to prove genuine use or produce justified reasons for non-use of their trade marks within the last five years that they cite as grounds for the opposition, if so requested by the applicant. Accordingly, if the opponent cannot prove genuine use or produce justified reasons for non-use, the opposition will be rejected.

There are also changes relating to opposition grounds. The protection of well-known trade marks in the meaning of Paris Convention, which was recently cancelled by the Constitutional Court, has been re-introduced as a relative opposition ground.

Finally, it is worth noting that for trade mark applications that were filed before January 10 2017, the former legislation, namely the Trademark Decree-Law, will still apply until their registration processes complete.

Uğur Aktekin

Mutlu Yıldırım Köse

Gün + Partners

Kore Şehitleri Cad. 17

Zincirlikuyu 34394

İstanbul, Turkey

Tel: + (90) (212) 354 00 00

Fax: + (90) (212) 274 20 95

gun@gun.av.tr

gun.av.tr

more from across site and SHARED ros bottom lb

More from across our site

Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Gift this article